Insiders · Profile

Lee Tien-Li

Chief Executive Officer at Aardvark Therapeutics. Filing since 14 Feb 2025. CIK 0001940120

Company
Date
Role
Action
Shares
Amount
Of holding
11 Dec 2025
Chief Executive Officer
Bought
7,000
$101.40K
0.5%
15 Sep 2025
Chief Executive Officer
Bought
10,000
$96.62K
0.7%
12 Sep 2025
Chief Executive Officer
Bought
5,000
$42.52K
0.3%
11 Sep 2025
Chief Executive Officer
Bought
6,000
$46.93K
0.4%
10 Sep 2025
Chief Executive Officer
Bought
9,000
$71.21K
0.6%
14 Feb 2025
Chief Executive Officer
Bought
16,542
$264.67K
1.1%
6 decisions on file.